The Lancet: October 16, 2014

Robert Lanza discusses two-year follow-up findings of human embryonic stem-cell transplantation in the potential treatment of Stargardt's Macular dystrophy and age-related macular degeneration.

Source: Listen to The Lancet - October 16, 2014 Category: General Medicine Authors: The Lancet Source Type: podcasts